0

    543594

    DPL

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    DIPNA PHARMACHEM LIMITED Share Price Today

    Investment Returns

    Over 1 Month -17.54% Over 3 Months -34.22% Over 6 Months -59.45% Over 1 Year -75.83%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    DIPNA PHARMACHEM LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 15.60
    • P/E Ratio (TTM) 5.92
    • Beta 0.47
    • Book Value / share 23.69
    • Return on equity 2.55%
    • EPS (TTM) 1.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.18
    info icon alternate text

    DIPNA PHARMACHEM LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 2.02
    Operating Expense 1.83
    Net Profit 0.18
    Net Profit Margin (%) 8.91
    Earnings Per Share (EPS) 0.07
    EBITDA 0.45
    Effective Tax Rate (%) 18.18
    Particulars DEC 2025 (Values in Cr)
    Revenue 53.52
    Operating Expense 52.09
    Net Profit 1.04
    Net Profit Margin (%) 1.94
    Earnings Per Share (EPS) 0.40
    EBITDA 1.65
    Effective Tax Rate (%) 26.05
    Particulars MAR 2025 (Values in Cr)
    Revenue 15.92
    Operating Expense 15.24
    Net Profit 0.50
    Net Profit Margin (%) 3.14
    Earnings Per Share (EPS) 0.21
    EBITDA 1.28
    Effective Tax Rate (%) 26.47
    Particulars DEC 2024 (Values in Cr)
    Revenue 18.38
    Operating Expense 0.00
    Net Profit 0.14
    Net Profit Margin (%) 0.76
    Earnings Per Share (EPS) 0.06
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 129.08
    Operating Expense 125.55
    Net Profit 2.63
    Net Profit Margin (%) 2.03
    Earnings Per Share (EPS) 1.00
    EBITDA 5.01
    Effective Tax Rate (%) 25.70
    Particulars MAR 2025 (Values in Cr)
    Revenue 124.92
    Operating Expense 123.50
    Net Profit 0.97
    Net Profit Margin (%) 0.77
    Earnings Per Share (EPS) 0.41
    EBITDA 3.74
    Effective Tax Rate (%) 31.69
    Particulars MAR 2024 (Values in Cr)
    Revenue 164.34
    Operating Expense 162.93
    Net Profit 1.09
    Net Profit Margin (%) 0.66
    Earnings Per Share (EPS) 0.90
    EBITDA 3.44
    Effective Tax Rate (%) 23.23
    Particulars MAR 2023 (Values in Cr)
    Revenue 99.93
    Operating Expense 98.55
    Net Profit 0.91
    Net Profit Margin (%) 0.91
    Earnings Per Share (EPS) 0.76
    EBITDA 2.34
    Effective Tax Rate (%) 34.05
    Particulars MAR 2022 (Values in Cr)
    Revenue 72.76
    Operating Expense 71.19
    Net Profit 1.17
    Net Profit Margin (%) 1.60
    Earnings Per Share (EPS) 333.39
    EBITDA 2.21
    Effective Tax Rate (%) 26.11
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 16.01
    ROE % 2.55
    ROCE % 6.64
    Total Debt to Total Equity 0.48
    EBITDA Margin 3.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 15.60
    ROE % 3.52
    ROCE % 7.05
    Total Debt to Total Equity 0.57
    EBITDA Margin 2.10
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 20.35
    ROE % 6.97
    ROCE % 9.00
    Total Debt to Total Equity 1.00
    EBITDA Margin 2.36
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 496.73
    ROE % 100.86
    ROCE % 17.56
    Total Debt to Total Equity 9.75
    EBITDA Margin 3.01
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 163.34
    ROE % 3.54
    ROCE % 3.46
    Total Debt to Total Equity 19.47
    EBITDA Margin 1.32
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.42
    Total Assets 132.37
    Total Liabilities 132.37
    Total Equity 38.49
    Share Outstanding 2
    Price to Book Ratio 0.89
    Return on Assets (%) 0.73
    Return on Capital (%) 1.75
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 13.87
    Total Assets 132.90
    Total Liabilities 132.90
    Total Equity 37.51
    Share Outstanding 2
    Price to Book Ratio 0.60
    Return on Assets (%) 0.81
    Return on Capital (%) 1.91
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 5.69
    Total Assets 77.55
    Total Liabilities 77.55
    Total Equity 24.35
    Share Outstanding 1
    Price to Book Ratio 0.62
    Return on Assets (%) 1.17
    Return on Capital (%) 2.26
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.20
    Total Assets 36.22
    Total Liabilities 36.22
    Total Equity 1.73
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 3.22
    Return on Capital (%) 9.78
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.25
    Total Assets 24.79
    Total Liabilities 24.79
    Total Equity 0.57
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.09
    Return on Capital (%) 0.19
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.42
    Cash from Operations -8.74
    Cash from Investing -0.02
    Cash from Financing -4.23
    Net change in Cash -13.45
    Free Cash Flow -8.72
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.41
    Cash from Operations -5.08
    Cash from Investing -0.01
    Cash from Financing 13.61
    Net change in Cash 8.18
    Free Cash Flow -5.06
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.38
    Cash from Operations -20.50
    Cash from Investing -0.01
    Cash from Financing 26.47
    Net change in Cash 5.48
    Free Cash Flow -20.49
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.57
    Cash from Operations 3.21
    Cash from Investing 0.00
    Cash from Financing -2.84
    Net change in Cash -0.04
    Free Cash Flow 3.21
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.05
    Cash from Operations -2.41
    Cash from Investing 0.00
    Cash from Financing 2.50
    Net change in Cash 0.07
    Free Cash Flow -2.40
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 13.52 1.58 250.74 23.12 38.85
    BLISS GVS PHARMA LTD 506.15 40.69 4.49 5368.04 118.35 552.90
    CIPLA LTD. 1458.45 30.95 3.42 117820.20 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 345.85 15.26 2.50 1017.87 256.40 399.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2392.75 42.13 17.87 40534.63 2088.00 3362.55
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 22.88 4.21 250.74 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.85 24.06 4.19 1552.07 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8297.90 108.37 23.76 20744.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 506.15 54.72 4.64 5368.04 118.35 552.90

    DIPNA PHARMACHEM LIMITED shareholding pattern

    Holding
    90.87%
    9.12%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    DIPNA PHARMACHEM LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    5.92 0.00 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 6.40
    • 26 Days 7.20
    • 10 Days 6.70
    • 50 Days 7.90
    • 12 Days 6.80
    • 100 Days 9.60
    • 20 Days 7.00
    • 200 Days 12.00
    6.17 PIVOT
    First Support 5.87 First Resistance 6.34 Second Support 5.70 Second Resistance 6.64 Third Support 5.40 Third Resistance 6.81
    RSI 30.73 ADX 14.09 MACD -0.39 Williams % R -84.62 Commodity Channel Index (CCI) -227.54
    Date 2026-07-03 Week 132000.00 Same Day 213000.00 Month 63333.00
    1 Year 0.48 3 Year 0.52
    Over 1 Month
    -17.54% down
    Over 1 Year
    -75.83% down
    Over 3 Months
    -34.22% down
    Over 3 Years
    -32.30% down
    Over 6 Months
    -59.45% down
    Over 5 Years
    0.00% down

    DIPNA PHARMACHEM LIMITED Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Dipna Pharmachem Ltd?

    Answer Field

    Dipna Pharmachem Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 5.92 as on Jul 06 2026 10:07 AM.

    What is the Market Cap of Dipna Pharmachem Ltd Share?

    Answer Field

    The market cap of Dipna Pharmachem Ltd for NSE ₹ 0.00 & for BSE ₹ 15.60 as on Jul 06 2026 10:07 AM.

    What is the 52 Week High and Low of Dipna Pharmachem Ltd?

    Answer Field

    The 52 Week High and Low of Dipna Pharmachem Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 25.66 and ₹ 5.56.

    What is 1 year return for Dipna Pharmachem Ltd?

    Answer Field

    The 1 year returns on the stock has been -75.83%.

    What is the P/E Ratio of Dipna Pharmachem Ltd Share?

    Answer Field

    As on Jul 06 2026 10:07 AM the price-to-earnings (PE) ratio for Dipna Pharmachem Ltd share is 5.92.

    What is the PB ratio of Dipna Pharmachem Ltd Share?

    Answer Field

    As on Jul 06 2026 10:07 AM, the price-to-book (PB) ratio for Dipna Pharmachem Ltd share is 23.69.

    How to Buy Dipna Pharmachem Ltd Share?

    Answer Field

    You can trade in Dipna Pharmachem Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Dipna Pharmachem Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Dipna Pharmachem Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Dipna Pharmachem Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |